Literature DB >> 22535711

Nonparametric multistate representations of survival and longitudinal data with measurement error.

Bo Hu1, Liang Li, Xiaofeng Wang, Tom Greene.   

Abstract

This paper proposes a nonparametric procedure to describe the progression of longitudinal cohorts over time from a population averaged perspective, leading to multistate probability curves with the states defined jointly by survival and longitudinal outcomes measured with error. To account for the challenges of informative dropout and nonlinear shapes of the longitudinal trajectories, we apply a bias corrected penalized spline regression to estimate the unobserved longitudinal trajectory for each subject. We then estimate the multistate probability curves on the basis of the survival data and the estimated longitudinal trajectories. We further use simulation-extrapolation method to reduce the estimation bias caused by the randomness of the estimated trajectories. We develop a bootstrap test to compare multistate probability curves between groups. We present theoretical justification of the estimation procedure along with a simulation study to demonstrate finite sample performance. We illustrate the procedure by data from the African American Study of Kidney Disease and Hypertension, and it can be widely applied in longitudinal studies.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22535711      PMCID: PMC3845220          DOI: 10.1002/sim.5369

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  15 in total

1.  Analysis of change in the presence of informative censoring: application to a longitudinal clinical trial of progressive renal disease.

Authors:  M D Schluchter; T Greene; G J Beck
Journal:  Stat Med       Date:  2001-04-15       Impact factor: 2.373

Review 2.  Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK).

Authors:  Garabed Eknoyan; Thomas Hostetter; George L Bakris; Lee Hebert; Andrew S Levey; Hans-Henrik Parving; Michael W Steffes; Robert Toto
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

3.  Methods for the analysis of informatively censored longitudinal data.

Authors:  M D Schluchter
Journal:  Stat Med       Date:  1992 Oct-Nov       Impact factor: 2.373

4.  Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data.

Authors:  Jun Xie; Chaofeng Liu
Journal:  Stat Med       Date:  2005-10-30       Impact factor: 2.373

5.  Tutorial in biostatistics: competing risks and multi-state models.

Authors:  H Putter; M Fiocco; R B Geskus
Journal:  Stat Med       Date:  2007-05-20       Impact factor: 2.373

Review 6.  The truncation-by-death problem: what to do in an experimental evaluation when the outcome is not always defined.

Authors:  Sheena McConnell; Elizabeth A Stuart; Barbara Devaney
Journal:  Eval Rev       Date:  2008-04

7.  Analysing changes in the presence of informative right censoring caused by death and withdrawal.

Authors:  M C Wu; K Bailey
Journal:  Stat Med       Date:  1988 Jan-Feb       Impact factor: 2.373

8.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Authors:  Jackson T Wright; George Bakris; Tom Greene; Larry Y Agodoa; Lawrence J Appel; Jeanne Charleston; DeAnna Cheek; Janice G Douglas-Baltimore; Jennifer Gassman; Richard Glassock; Lee Hebert; Kenneth Jamerson; Julia Lewis; Robert A Phillips; Robert D Toto; John P Middleton; Stephen G Rostand
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

9.  Estimating smooth distribution function in the presence of heteroscedastic measurement errors.

Authors:  Xiao-Feng Wang; Zhaozhi Fan; Bin Wang
Journal:  Comput Stat Data Anal       Date:  2010-01-01       Impact factor: 1.681

10.  Factors other than glomerular filtration rate affect serum cystatin C levels.

Authors:  Lesley A Stevens; Christopher H Schmid; Tom Greene; Liang Li; Gerald J Beck; Marshall M Joffe; Marc Froissart; John W Kusek; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey
Journal:  Kidney Int       Date:  2008-12-31       Impact factor: 10.612

View more
  2 in total

1.  Joint multiple imputation for longitudinal outcomes and clinical events that truncate longitudinal follow-up.

Authors:  Bo Hu; Liang Li; Tom Greene
Journal:  Stat Med       Date:  2015-07-15       Impact factor: 2.373

Review 2.  Regression methods for investigating risk factors of chronic kidney disease outcomes: the state of the art.

Authors:  Julie Boucquemont; Georg Heinze; Kitty J Jager; Rainer Oberbauer; Karen Leffondre
Journal:  BMC Nephrol       Date:  2014-03-14       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.